Your Laboratory Trends Indicate Significant Clinical Improvement with Resolving Infection
Your blood work shows excellent response to treatment: CRP dropping from 348 to 22 mg/L, WCC from 22.5 to 14.0 ×10⁹/L, and neutrophils from 18.38 to 8.01 ×10⁹/L demonstrate that your dental infection and systemic inflammation are resolving, though not yet fully controlled. This trajectory supports continuing your current steroid taper while addressing the underlying dental source and optimizing your RA management.
What These Numbers Mean
Infection Resolution
Your inflammatory markers show dramatic improvement but remain elevated:
- CRP at 22 mg/L (normal <10): Down 94% from peak, indicating the acute infection is largely controlled but residual inflammation persists 1
- WCC at 14.0 ×10⁹/L (normal 4-11): Approaching normal range, consistent with resolving bacterial infection 2, 1
- Neutrophils at 8.01 ×10⁹/L (normal 2-7.5): Nearly normalized, suggesting the acute bacterial phase is ending 3
These trends are consistent with successful treatment of your odontogenic infection, though complete resolution requires several more weeks 2.
Steroid Effect vs. Disease Activity
Your improving markers likely reflect both infection control AND steroid therapy. The challenge now is distinguishing residual infection from underlying RA activity as you taper steroids.
Critical Next Steps
1. Complete Dental Source Control (Immediate Priority)
- Ensure definitive treatment of the infected tooth/jaw abscess
- Residual dental infection will prevent full normalization of inflammatory markers 2
- CRP >20 mg/L with dental pathology suggests incomplete source control 1
2. Monitor During Steroid Taper (Every 2-4 Weeks)
Continue checking CRP, WCC, and clinical joint assessment as you reduce steroids 4, 5:
- If CRP rises >50 mg/L or WCC >15: Consider infection recurrence or RA flare
- If CRP stabilizes 10-30 mg/L: Likely represents baseline RA activity requiring DMARD optimization
- If CRP normalizes <10 mg/L: Suggests good infection control and RA disease control
3. DMARD Strategy Optimization
Given your multi-organ involvement (hepatic, renal, pulmonary) and seropositive status, you require aggressive RA management 5:
Once infection fully cleared (CRP <10 mg/L for 2 consecutive weeks):
- Methotrexate should be your anchor DMARD unless contraindicated by your hepatic/renal/pulmonary involvement 5, 6
- If MTX contraindicated: Leflunomide or sulfasalazine as alternatives 5
- Target remission or low disease activity (DAS28-CRP <3.2) 5, 7
4. Address Comorbidities Affecting Treatment
Your multi-organ involvement creates specific constraints 5:
- Pulmonary involvement: May limit MTX options; consider alternative DMARDs or careful MTX initiation with close monitoring 8
- Renal involvement: Requires dose adjustments and more frequent monitoring 4
- Hepatic involvement: May preclude MTX; prioritize sulfasalazine or biologics 5
Common Pitfalls to Avoid
Don't taper steroids too rapidly while infection markers remain elevated—this risks both infection recurrence and RA flare 5. The guideline recommendation is taper "as rapidly as clinically feasible" but only after achieving disease control.
Don't attribute all inflammation to RA alone—with your dental infection history, any CRP elevation >30 mg/L warrants infection workup before escalating immunosuppression 2, 1.
Don't delay DMARD optimization—once infection clears, you need aggressive RA treatment given your seropositive status and organ involvement 5. Waiting months risks irreversible joint and organ damage.
Radiological Changes Your Provider Mentioned
The "permanent radiological change" likely refers to:
- Pulmonary: Residual fibrosis or scarring from inflammation (may take 3-6 months to stabilize)
- Joints: Erosive changes from RA (irreversible but preventable with proper treatment)
This underscores the urgency of achieving remission to prevent further structural damage 5, 7.
Timeline Expectations
- Infection markers: Should normalize (CRP <10) within 4-8 weeks with proper dental treatment 2, 1
- Steroid taper: Should complete within 3-6 months maximum 5
- DMARD effect: Takes 3-6 months to reach maximum efficacy 5
- Radiological resolution: May take 3-12 months for pulmonary changes to stabilize
Your current trajectory is encouraging, but close monitoring every 2-4 weeks during steroid taper is essential to catch either infection recurrence or RA flare early 4, 5.